139 related articles for article (PubMed ID: 16369748)
1. Small cell carcinoma of the esophagus responding to fourth-line chemotherapy with weekly paclitaxel.
Matsuoka M; Boku N; Yoshino T; Hironaka S; Onozawa Y; Fukutomi A; Zenda S; Yamazaki K; Yasui H; Hasuike N; Inui T; Yamaguchi Y; Ono H; Kamata M
Int J Clin Oncol; 2005 Dec; 10(6):429-32. PubMed ID: 16369748
[TBL] [Abstract][Full Text] [Related]
2. A case of esophageal small cell carcinoma with multiple liver metastases responding to chemotherapy with irinotecan plus cisplatin.
Endo K; Kohnoe S; Toh Y; Haraguchi M; Nishiyama K; Okamura T; Baba H; Maehara Y
J Exp Clin Cancer Res; 2005 Dec; 24(4):647-50. PubMed ID: 16471329
[TBL] [Abstract][Full Text] [Related]
3. Effective combination chemotherapy of carboplatin and paclitaxel in the treatment of a recurrent small-cell lung cancer patient.
Kaira K; Ishizuka T; Yanagitani N; Sunaga N; Hisada T; Mori M
Gan To Kagaku Ryoho; 2007 Feb; 34(2):225-7. PubMed ID: 17301532
[TBL] [Abstract][Full Text] [Related]
4. Selective dose escalation of chemoradiotherapy for esophageal cancer: role of treatment intensification.
Seung SK; Smith JW; Molendyk J; Bader SB; Phillips M; Regan J; Louie J; Soo E; Seligman M; Ruzich J; Skokan L; Ross HJ
Semin Oncol; 2004 Dec; 31(6 Suppl 18):13-9. PubMed ID: 15726517
[TBL] [Abstract][Full Text] [Related]
5. [A patient with stage IVb small cell carcinoma of the esophagus who survived 23 months after systemic cancer chemotherapy].
Tsujie M; Shibata N; Nomura T; Tanaka T; Morimoto T; Fujita S; Kitani K; Nakahira S; Okuda H; Takeda M
Gan To Kagaku Ryoho; 2003 Feb; 30(2):271-5. PubMed ID: 12610878
[TBL] [Abstract][Full Text] [Related]
6. [A case of malignant melanoma from the esophagus responding to weekly paclitaxel therapy].
Kakudo Y; Yoshioka T; Noguchi S; Hanada M; Otsuka K; Sakayori M; Chiba N; Shibata H; Kato S; Shimodaira H; Ohori H; Takahashi S; Takahashi M; Yamaura G; Yasuda K; Ishioka C
Gan To Kagaku Ryoho; 2006 Jul; 33(7):969-72. PubMed ID: 16835489
[TBL] [Abstract][Full Text] [Related]
7. [A case of advanced esophageal cancer with liver metastases: efficacy of combination therapy of docetaxel/cisplatin/5-FU].
Ehara K; Tsutsumi K; Kinoshita Y; Ueno M; Mine S; Udagawa H
Gan To Kagaku Ryoho; 2008 Aug; 35(8):1375-8. PubMed ID: 18701852
[TBL] [Abstract][Full Text] [Related]
8. [A patient with small-cell carcinoma of the esophagus with synchronous liver metastasis surviving 48 months after surgery].
Nagahama T; Maruyama M; Tokairin Y; Yoshida T; Baba H; Kure N; Ebuchi M
Gan To Kagaku Ryoho; 2001 Oct; 28(11):1655-8. PubMed ID: 11708001
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.
Ilson DH; Ajani J; Bhalla K; Forastiere A; Huang Y; Patel P; Martin L; Donegan J; Pazdur R; Reed C; Kelsen DP
J Clin Oncol; 1998 May; 16(5):1826-34. PubMed ID: 9586897
[TBL] [Abstract][Full Text] [Related]
10. [A case report of small cell carcinoma of the esophagus successfully treated by irinotecan and cisplatin].
Nagahama T; Ando M; Ohbu M; Ami K; Ganno H; Taira M; Ito T
Gan To Kagaku Ryoho; 2006 Nov; 33(12):1869-71. PubMed ID: 17212131
[TBL] [Abstract][Full Text] [Related]
11. [A case of a 14-month survival patient on advanced esophageal cancer with uncontrolled brain metastasis completely responding to nedaplatin, adriamycin, plus 5-FU (NAF) therapy].
Iijima S; Makari Y; Kato T; Ooshima S; Hoshi M; Doi T; Miyake Y; Sakamoto T; Kato A; Miyo M; Kurokawa E; Kikkawa N
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2052-4. PubMed ID: 20037320
[TBL] [Abstract][Full Text] [Related]
12. [A case of small cell undifferentiated carcinoma of the esophagus successfully treated by chemoradiotherapy].
Kitagawa H; Akimori T; Namikawa T; Okino T; Kobayashi M; Nishioka A; Hanazaki K
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1737-9. PubMed ID: 19838038
[TBL] [Abstract][Full Text] [Related]
13. Prospective non-randomized study of preoperative concurrent platinum plus 5-fluorouracil-based chemoradiotherapy with or without paclitaxel in esophageal cancer patients: long-term follow-up.
Zemanova M; Petruzelka L; Pazdro A; Kralova D; Smejkal M; Pazdrova G; Honova H
Dis Esophagus; 2010 Feb; 23(2):160-7. PubMed ID: 19515190
[TBL] [Abstract][Full Text] [Related]
14. Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study.
Ettinger DS; Berkey BA; Abrams RA; Fontanesi J; Machtay M; Duncan PJ; Curran WJ; Movsas B; Byhardt RW;
J Clin Oncol; 2005 Aug; 23(22):4991-8. PubMed ID: 15939930
[TBL] [Abstract][Full Text] [Related]
15. A phase II study of concurrent chemoradiotherapy combined with a weekly paclitaxel and 5-fluorouracil regimen to treat patients with advanced oesophageal carcinoma.
Xia Y; Li YH; Chen Y; Zhang JH; Liu Q; Deng JY; Ai TS; Zhu HT; Fan JH; Badakhshi H; Zhao KL
Radiat Oncol; 2017 Mar; 12(1):47. PubMed ID: 28270162
[TBL] [Abstract][Full Text] [Related]
16. [A case of small cell carcinoma of the esophagus with remarkable response to chemotherapy with CPT-11 and CDDP].
Goto T; Watabe H; Kawakami T; Watanabe M; Nakano K; Takai A; Kitazawa E; Sato S; Tajima Y; Mizuguchi K; Kikuchi K; Miyakawa H; Murakawa Y
Nihon Shokakibyo Gakkai Zasshi; 2007 Aug; 104(8):1204-11. PubMed ID: 17675822
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant therapy with weekly docetaxel and cisplatin, 5-fluorouracil continuous infusion, and concurrent radiotherapy in patients with locally advanced esophageal cancer produced a high percentage of long-lasting pathological complete response: a phase 2 study.
Pasini F; de Manzoni G; Zanoni A; Grandinetti A; Capirci C; Pavarana M; Tomezzoli A; Rubello D; Cordiano C
Cancer; 2013 Mar; 119(5):939-45. PubMed ID: 23165781
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma.
Hsu C; Huang CS; Chao TY; Lu YS; Bu CF; Chen MM; Chang KJ; Cheng AL
Cancer; 2002 Nov; 95(10):2044-50. PubMed ID: 12412156
[TBL] [Abstract][Full Text] [Related]
19. Multicenter phase II trial of paclitaxel, cisplatin, and etoposide with concurrent radiation for limited-stage small-cell lung cancer.
Bremnes RM; Sundstrøm S; Vilsvik J; Aasebø U;
J Clin Oncol; 2001 Aug; 19(15):3532-8. PubMed ID: 11481360
[TBL] [Abstract][Full Text] [Related]
20. Multi-institutional phase I/II trial of paclitaxel, cisplatin, and etoposide with concurrent radiation for limited-stage small-cell lung carcinoma.
Levitan N; Dowlati A; Shina D; Craffey M; Mackay W; DeVore R; Jett J; Remick SC; Chang A; Johnson D
J Clin Oncol; 2000 Mar; 18(5):1102-9. PubMed ID: 10694563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
